{"gene":"PACS1","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":1998,"finding":"PACS-1 directs TGN localization of furin by binding to the protease's phosphorylated cytosolic acidic cluster domain, acting as a coat protein that connects furin to clathrin-sorting machinery; cell-free assays showed TGN localization is directed by a PACS-1-mediated retrieval step from endosomes.","method":"In vitro binding assays, cell-free TGN localization assays, antisense studies, co-immunoprecipitation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution in cell-free assay, multiple orthogonal methods, foundational paper with 330 citations","pmids":["9695949"],"is_preprint":false},{"year":2000,"finding":"HIV-1 Nef binds PACS-1 via its acidic cluster (EEEE motif) to redirect internalized MHC-I from the cell surface to the TGN; Nef acts as a connector between MHC-I cytoplasmic tail and the PACS-1-dependent sorting pathway.","method":"Co-immunoprecipitation, chimeric protein localization, dominant-negative PACS-1 expression, confocal microscopy","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal functional assays, replicated mechanistic finding, 251 citations","pmids":["10707087"],"is_preprint":false},{"year":2001,"finding":"PACS-1 associates with adaptor complexes AP-1 and AP-3 (but not AP-2), forming a ternary complex with furin and AP-1; a short sequence in PACS-1 is essential for AP-1 binding, and dominant-negative PACS-1 (which binds cargo but not adaptors) mislocalizes furin, mannose-6-phosphate receptor, and blocks Nef-mediated MHC-I downregulation.","method":"Co-immunoprecipitation, dominant-negative mutant expression, subcellular fractionation, immunofluorescence","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, dominant-negative rescue experiments with defined phenotype, 164 citations","pmids":["11331585"],"is_preprint":false},{"year":2002,"finding":"Nef and PACS-1 combine to usurp the ARF6 endocytic pathway in a PI3K-dependent manner to downregulate cell-surface MHC-I to the TGN; three hierarchical Nef motifs (acidic cluster EEEE65, SH3-binding PXXP, and M20) control PACS-1-dependent TGN sorting, ARF6 activation, and MHC-I sequestration, respectively.","method":"Dominant-negative constructs, RNA interference, epistasis analysis, immunofluorescence, co-immunoprecipitation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — epistasis with multiple Nef motif mutants, mechanistic dissection with defined phenotypic readouts, 247 citations","pmids":["12526811"],"is_preprint":false},{"year":2003,"finding":"PACS-1 interacts with the cytoplasmic acidic cluster domain of HCMV glycoprotein B (gB) and is required for normal TGN localization of gB; inhibition of PACS-1 decreases HCMV titer while overexpression increases titer.","method":"Co-immunoprecipitation, dominant-negative PACS-1 expression, virus titer assays, immunofluorescence","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 2 — functional rescue with overexpression/inhibition plus binding assays, multiple orthogonal methods","pmids":["14512558"],"is_preprint":false},{"year":2003,"finding":"PACS-1 mediates phosphorylation-dependent recruitment to VAMP4 by binding the phosphorylated acidic cluster (Ser30) of VAMP4, thereby enhancing AP-1 association with VAMP4 cargo; dominant-negative PACS-1 causes mislocalization of VAMP4 in the regulated secretory pathway.","method":"Co-immunoprecipitation, dominant-negative PACS-1 expression, immunofluorescence, casein kinase 2 phosphorylation assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with defined cargo phosphorylation and phenotypic readout","pmids":["14608369"],"is_preprint":false},{"year":2005,"finding":"PACS-1 interacts with nephrocystin in a CK2-phosphorylation-dependent manner; CK2 phosphorylation of three critical serines in nephrocystin's acidic cluster mediates PACS-1 binding and is essential for nephrocystin localization to the base of cilia; CK2 inhibition disrupts this interaction and abrogates correct nephrocystin targeting.","method":"Co-immunoprecipitation, kinase inhibition assays, immunofluorescence, dominant-negative studies","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — phosphorylation mechanism defined with multiple methods and functional consequence (ciliary targeting)","pmids":["16308564"],"is_preprint":false},{"year":2006,"finding":"PACS-1 forms a multimeric complex with GGA3 and CK2 that controls CI-MPR sorting; PACS-1-bound CK2 phosphorylates GGA3 (releasing it from CI-MPR/endosomes) and phosphorylates PACS-1 Ser278 (promoting PACS-1 binding to CI-MPR for retrieval to TGN), constituting a CK2-controlled phosphorylation cascade.","method":"Co-immunoprecipitation, in vitro kinase assays, dominant-negative constructs, phospho-specific antibodies, immunofluorescence","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay plus multiple orthogonal in vivo methods defining a phosphorylation cascade","pmids":["16977309"],"is_preprint":false},{"year":2007,"finding":"PACS-1 is required for SorLA localization to TGN compartments; SorLA interaction with PACS-1 (and GGA) controls intracellular routing of SorLA/APP complexes, and aberrant SorLA targeting caused by loss of PACS-1 function results in increased amyloidogenic APP processing.","method":"Co-immunoprecipitation, dominant-negative PACS-1, siRNA knockdown, immunofluorescence, ELISA for Aβ","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assays plus loss-of-function with defined biochemical readout (Aβ production)","pmids":["17855360"],"is_preprint":false},{"year":2007,"finding":"Knockdown of PACS-1 by siRNA does not inhibit Nef-mediated downregulation of HLA-A2 in HeLa cells, and does not affect localization of other acidic-cluster-motif proteins; instead, AP-1 and clathrin are required, and Nef reroutes MHC-I to endosomes rather than TGN.","method":"siRNA knockdown, immunoelectron microscopy, flow cytometry, immunofluorescence","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — clean siRNA KD with defined phenotypic readout, but contradicts prior model; single lab study","pmids":["17581864"],"is_preprint":false},{"year":2009,"finding":"PACS-1 is expressed in olfactory sensory neurons and interacts with the CNG channel subunit CNGB1b; CK2 phosphorylates two acidic cluster sites on CNGB1b to enable PACS-1 binding; CK2 inhibition or dominant-negative PACS-1 expression causes loss of CNG channel from cilia and olfactory dysfunction.","method":"Co-immunoprecipitation, adenoviral dominant-negative expression, CK2 inhibition, electrophysiology, immunofluorescence","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with defined functional consequence (olfactory dysfunction), phosphorylation mechanism validated","pmids":["19710307"],"is_preprint":false},{"year":2012,"finding":"HIV-1 Nef interacts with PACS-1 and PACS-2 through a bipartite site on Nef (EEEE65 acidic cluster and W113 in core domain) engaging a previously unidentified cargo subsite on PACS proteins; this interaction occurs on Rab5/Rab7-positive endosomes and is required for Nef-mediated MHC-I downregulation in PBMCs.","method":"Bimolecular fluorescence complementation, site-directed mutagenesis, co-immunoprecipitation, flow cytometry, immunofluorescence","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis of interacting sites with multiple orthogonal in vivo/in cellulo methods and functional readout","pmids":["22496420"],"is_preprint":false},{"year":2012,"finding":"Recurrent de novo PACS1 mutation (p.Arg203Trp) causes PACS1 protein to form cytoplasmic aggregates with increased protein stability, shows impaired binding to an isoform-specific TRPV4 variant, and expression of mutant PACS1 mRNA in zebrafish induces craniofacial defects by disrupting SOX10-positive cranial neural crest cell specification and migration.","method":"In vitro aggregation assay, co-immunoprecipitation (binding to TRPV4), zebrafish mRNA injection, in situ hybridization (SOX10 marker)","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including in vivo zebrafish model with defined cellular phenotype","pmids":["23159249"],"is_preprint":false},{"year":2013,"finding":"PACS1 interaction with SORLA is required for SORLA/APP complex sorting to the TGN in neurons; disruption of SORLA-PACS1 interaction (by PACS1 knockdown or PACS1-binding-defective SORLA knock-in mice) increases APP processing in the brain; PACS1 loss also impairs CI-MPR and cathepsin B expression, reducing Aβ degradation.","method":"siRNA knockdown in neuronal lines, transgenic knock-in mice with PACS1-binding-defective SORLA, ELISA for Aβ, immunofluorescence","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo mouse model plus neuronal cell line KD with defined biochemical readout","pmids":["24001769"],"is_preprint":false},{"year":2017,"finding":"PACS1 regulates intrinsic (mitochondrial) apoptosis: PACS1 knockdown renders cells refractory to mitochondrial pathway death stimuli (granzyme B, staurosporine, UV, etoposide) but not TRAIL; protected cells fail to release cytochrome c due to perturbed BAX and BAK oligomerization; PCAF and ADA3 transcriptionally regulate PACS1 expression.","method":"siRNA knockdown, cytochrome c release assay, BAX/BAK oligomerization assay, cell death assays, ChIP","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — clean KD with multiple death stimuli tested and molecular readout (BAX/BAK oligomerization, cytochrome c), multiple orthogonal methods","pmids":["28060382"],"is_preprint":false},{"year":2017,"finding":"Par3 promotes BACE1 retrograde trafficking from endosomes to TGN through aPKC-mediated phosphorylation of BACE1 Ser498, which promotes BACE1 interaction with PACS-1 and facilitates endosome-to-TGN retrieval; decreased Ser498 phosphorylation is found in AD brains.","method":"Co-immunoprecipitation, site-directed mutagenesis, dominant-negative aPKC, immunofluorescence, human AD brain phospho-western blot","journal":"Neurobiology of aging","confidence":"High","confidence_rationale":"Tier 2 — phosphorylation-dependent binding mechanistically defined with mutagenesis and loss-of-function, validated in human tissue","pmids":["28946017"],"is_preprint":false},{"year":2018,"finding":"PACS-1 and AP-1 are required for targeting POMC/ACTH to dense core secretory granules (DCSGs); knockdown of PACS-1 or AP-1 causes POMC to be secreted constitutively rather than sorted to DCSGs.","method":"siRNA knockdown, ELISA for secreted ACTH, immunofluorescence","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — KD with phenotypic readout but single lab, limited mechanistic follow-up","pmids":["30458990"],"is_preprint":false},{"year":2019,"finding":"PACS1 shuttles between nucleus and cytoplasm, associates with HIV-1 Rev protein and its cofactor CRM1, and promotes nuclear export of unspliced viral RNA; overexpression increases nuclear export and p24 expression, while siRNA depletion reduces viral RNA export via the Rev-CRM1 pathway.","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, nuclear fractionation, RT-PCR for viral RNA","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, co-IP plus KD/OE with viral RNA export readout, but limited mechanistic follow-up","pmids":["31759187"],"is_preprint":false},{"year":2020,"finding":"PACS-1 accumulates in the nucleus during cell cycle progression and interacts with HDAC2 and HDAC3; PACS-1 knockdown causes proteasome-mediated degradation of HDAC2/HDAC3, elevated H3K9 and H4K16 acetylation, and increased replication stress-induced DNA damage and genomic instability.","method":"Co-immunoprecipitation, siRNA knockdown, immunofluorescence, histone acetylation western blots, comet assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP plus KD with defined chromatin/genomic readout; single lab but multiple methods","pmids":["31988453"],"is_preprint":false},{"year":2021,"finding":"Pacs1 forms a complex with Wdr37 that is required for normal ER calcium handling in lymphocytes; deletion of Pacs1 causes peripheral lymphopenia, blunted Ca2+ release from ER after antigen receptor stimulation, diminished inositol triphosphate receptor expression, and increased ER/oxidative stress; disruption of Pacs1-Wdr37 also suppresses lymphoproliferative disease.","method":"Forward genetic screen in mice, Pacs1 knockout, calcium imaging, IP3R expression western blot, in vivo lymphoproliferation models","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — in vivo mouse KO with multiple mechanistic readouts, forward genetic screen origin adds robustness","pmids":["33630350"],"is_preprint":false},{"year":2021,"finding":"PACS-1 nuclear trafficking is mediated by interaction with importin alpha 5 (nuclear entry) and exportin 1/CRM1 (nuclear exit); a nuclear localization signal (NLS, residues 311-318) and nuclear export signal (NES3, residues 366-375) were identified; PACS-1 also forms a complex with RNA-binding protein PTBP1 in both nucleus and cytoplasm.","method":"Site-directed mutagenesis of NLS/NES, co-immunoprecipitation with importin alpha 5 and exportin 1, immunofluorescence of NLS/NES mutants","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis of transport signals with localization readout; single lab","pmids":["34822171"],"is_preprint":false},{"year":2023,"finding":"PACS1 is an HDAC6 effector; the R203W substitution increases the PACS1/HDAC6 interaction, aberrantly potentiating deacetylase activity; this reduces acetylation of α-tubulin and cortactin, causing Golgi ribbon fragmentation and overpopulation of dendrites, increased dendritic arborization, varicosities, reduced spine density, and fewer functional synapses in hippocampal neurons and patient-derived NPCs; treatment with PACS1- or HDAC6-targeting antisense oligonucleotides restores neuronal structure and synaptic transmission.","method":"Co-immunoprecipitation, HDAC6 activity assay, acetylation western blots, confocal microscopy of Golgi/dendrites, electrophysiology, ASO treatment in PACS1 syndrome mice","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro enzymatic assay + mutagenesis + in vivo rescue with multiple orthogonal methods in patient cells and mouse model","pmids":["37848409"],"is_preprint":false},{"year":2024,"finding":"PACS-1 interacts with TRPC3 calcium transporter and ESyt1 ER-plasma membrane tethering protein; PACS-1 promotes TRPC3-ESyt1 interactions and regulates their plasma membrane localization; PACS-1 is required for proper store-operated calcium entry (SOCE) response and for ESyt1-mediated regulation of ACTH secretion in corticotropic cells.","method":"Co-immunoprecipitation, siRNA knockdown, calcium imaging (SOCE assay), immunofluorescence, ACTH secretion ELISA","journal":"ACS omega","confidence":"Medium","confidence_rationale":"Tier 2-3 — binding plus functional calcium assay and secretion readout; single lab","pmids":["39157130"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure of the Pacs1-Wdr37 complex shows Pacs1 binds Wdr37 through its furin-binding region (FBR); this interaction stabilizes Wdr37 and is critical for expression of both proteins; the FBR has structural homology to synaptotagmin C2 domains and can bind negatively charged phospholipids through a unique positively charged cleft; the R203W pathogenic mutation lies on a solvent-exposed surface of the FBR and does not disrupt complex formation but remains dependent on Wdr37 for stability.","method":"Cryo-electron microscopy structure determination, targeted proteolysis, phospholipid binding assays","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure with functional validation of binding interface and phospholipid interaction","pmids":["41279321"],"is_preprint":true},{"year":2026,"finding":"Cytoplasmic dynein-1 heavy chain (DHC1) is a PACS1 interactor essential for maintaining furin localization at the TGN; PACS1R203W induces a dynein loss-of-function phenotype by recruiting BICD2 adaptor and forming a PACS1R203W-HDAC6-BICD2 complex that disperses the Golgi and impairs dynein-driven cargo motility (reduced initiation frequency and velocity); HDAC6 inhibition or Lis1 overexpression rescues dynein function.","method":"Co-immunoprecipitation, cargo motility assays, HDAC6 inhibition rescue, dominant-negative Lis1, immunofluorescence of Golgi/furin","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods defining complex, functional motility readout, and pharmacological rescue","pmids":["41888583"],"is_preprint":false},{"year":2026,"finding":"NMR solution structure of PACS-1 furin-binding region (FBR, residues 101-273) shows that the PACS-1/HDAC6 interaction is regulated by an intramolecular mechanism in which the central unstructured region of PACS-1 folds back across the FBR to engage a positively charged loop; the R203W substitution disrupts this intramolecular regulatory contact in vitro, promoting aberrant protein-protein interactions.","method":"NMR solution structure determination, in vitro binding assays with HDAC6, mutagenesis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional validation of intramolecular regulatory mechanism and mutagenesis","pmids":["41858172"],"is_preprint":false}],"current_model":"PACS-1 is a multifunctional cytosolic sorting protein whose furin-binding region (FBR) recognizes phosphorylated acidic cluster motifs on cargo proteins (furin, CI-MPR, VAMP4, BACE1, SorLA, nephrocystin, viral glycoproteins) and connects them to clathrin adaptor complexes (AP-1, AP-3) for CK2-regulated retrieval from endosomes to the TGN; it also acts as an HDAC6 effector controlling Golgi integrity and neuronal morphology, forms a stability complex with WDR37 through its FBR that can bind phospholipids, mediates nucleocytoplasmic shuttling via importin alpha 5 and CRM1, regulates ER calcium handling in lymphocytes through a Pacs1-Wdr37 complex, promotes BAX/BAK oligomerization in the intrinsic apoptosis pathway, and interacts with dynein/BICD2 to drive retrograde cargo transport; the recurrent R203W mutation disrupts an intramolecular regulatory mechanism within the FBR that normally restrains HDAC6 binding, leading to aberrant HDAC6 hyperactivation, tubulin/cortactin deacetylation, dynein dysfunction, Golgi fragmentation, and neuronal synaptic deficits characteristic of PACS1 neurodevelopmental syndrome."},"narrative":{"teleology":[{"year":1998,"claim":"The discovery that furin's TGN localization depends on a cytosolic adaptor recognizing its phosphorylated acidic cluster established PACS-1 as a new class of CK2-regulated sorting protein linking cargo to clathrin machinery.","evidence":"Cell-free TGN retrieval assay, in vitro binding, antisense knockdown in A7 melanoma cells","pmids":["9695949"],"confidence":"High","gaps":["No structural information on the cargo-recognition domain","Identity of clathrin adaptor partner not yet defined","Generality to non-furin cargo unknown"]},{"year":2001,"claim":"Identification of AP-1 and AP-3 (but not AP-2) as PACS-1 effector adaptors, and demonstration that dominant-negative PACS-1 mislocalizes furin, CI-MPR, and blocks Nef-mediated MHC-I downregulation, established the ternary cargo–PACS-1–adaptor sorting paradigm.","evidence":"Co-immunoprecipitation, dominant-negative PACS-1 expression, subcellular fractionation in multiple cell lines","pmids":["11331585","10707087"],"confidence":"High","gaps":["How CK2 phosphorylation of PACS-1 itself regulates adaptor binding was unknown","Whether PACS-1 requirement for Nef-MHC-I pathway is cell-type-dependent"]},{"year":2003,"claim":"Extension of the PACS-1 cargo repertoire to VAMP4 and HCMV glycoprotein B demonstrated that CK2-phosphorylated acidic clusters are a general sorting signal decoded by PACS-1 in both endogenous secretory and viral trafficking pathways.","evidence":"Co-IP, CK2 kinase assays, dominant-negative PACS-1, virus titer assays","pmids":["14608369","14512558"],"confidence":"High","gaps":["Structural basis for acidic-cluster selectivity unresolved","Role in neuronal cargo not yet tested"]},{"year":2006,"claim":"Discovery that PACS-1 scaffolds a CK2–GGA3 phosphorylation cascade controlling CI-MPR endosome-to-TGN retrieval revealed PACS-1 as both a kinase scaffold and a regulated cargo receptor whose own Ser278 phosphorylation gates cargo binding.","evidence":"In vitro kinase assays, phospho-specific antibodies, dominant-negative constructs, immunofluorescence","pmids":["16977309"],"confidence":"High","gaps":["Whether the CK2–PACS-1 complex regulates additional substrates beyond GGA3 is unexplored","In vivo validation of the cascade lacking"]},{"year":2007,"claim":"Linking PACS-1 to SorLA/APP trafficking in neurons showed that loss of PACS-1-mediated TGN retrieval increases amyloidogenic APP processing, connecting the sorting adaptor to Alzheimer's disease-relevant biology.","evidence":"Co-IP, siRNA, dominant-negative PACS-1, Aβ ELISA in neuronal cells; later confirmed in PACS1-binding-defective SorLA knock-in mice","pmids":["17855360","24001769"],"confidence":"High","gaps":["Whether PACS1 loss affects Aβ clearance pathways independently of SorLA","Human genetic association of PACS1 with AD risk not established"]},{"year":2009,"claim":"Demonstration that PACS-1 directs CNG channel subunit CNGB1b to olfactory cilia via CK2-dependent acidic cluster recognition extended the paradigm from Golgi/TGN sorting to ciliary targeting, with functional consequences for sensory neuron physiology.","evidence":"Co-IP, CK2 inhibition, dominant-negative adenoviral PACS-1, electrophysiology in olfactory neurons","pmids":["19710307"],"confidence":"High","gaps":["Whether PACS-1 accompanies cargo to the cilium or hands off to IFT machinery unknown"]},{"year":2012,"claim":"Identification of the recurrent R203W de novo mutation as the cause of PACS1 neurodevelopmental syndrome, with demonstration that mutant protein forms cytoplasmic aggregates and disrupts cranial neural crest specification in zebrafish, established PACS1 as a disease gene and implicated FBR integrity in brain development.","evidence":"Human exome sequencing, in vitro aggregation assay, zebrafish mRNA injection, SOX10 in situ hybridization","pmids":["23159249"],"confidence":"High","gaps":["Molecular mechanism by which R203W causes aggregation unresolved","Whether gain-of-function or dominant-negative effect uncertain at this stage"]},{"year":2017,"claim":"Discovery that PACS1 knockdown blocks BAX/BAK oligomerization and cytochrome c release revealed an unexpected role in the intrinsic apoptotic pathway, broadening PACS1 function beyond membrane trafficking.","evidence":"siRNA knockdown, cytochrome c release assay, BAX/BAK oligomerization, multiple death stimuli panel","pmids":["28060382"],"confidence":"High","gaps":["Direct physical mechanism linking PACS1 to BAX/BAK oligomerization not identified","Whether this reflects a trafficking-dependent or trafficking-independent function unclear"]},{"year":2020,"claim":"Finding that nuclear PACS-1 stabilizes HDAC2/HDAC3 to maintain histone deacetylation and protect against replication-stress-induced DNA damage revealed a chromatin-regulatory function separate from its TGN sorting role.","evidence":"Co-IP with HDAC2/HDAC3, siRNA, histone acetylation western blots, comet assay","pmids":["31988453"],"confidence":"Medium","gaps":["Whether PACS-1 directly shields HDACs from proteasomal targeting or acts indirectly is unclear","Independent replication needed","Relationship to cell-cycle-dependent nuclear accumulation not fully defined"]},{"year":2021,"claim":"Forward genetic identification of Pacs1–Wdr37 as a complex essential for ER calcium handling, IP3R expression, and lymphocyte survival established PACS1 in ER-related signaling and immune homeostasis.","evidence":"Mouse Pacs1 knockout, calcium imaging, IP3R western blot, in vivo lymphoproliferation models","pmids":["33630350"],"confidence":"High","gaps":["How the Pacs1–Wdr37 complex controls IP3R expression (transcriptional vs. post-translational) unknown","Whether the ER calcium defect contributes to PACS1 syndrome neuronal phenotypes untested"]},{"year":2023,"claim":"Demonstration that PACS1 is an HDAC6 effector and that R203W hyperactivates HDAC6 deacetylase activity, causing tubulin/cortactin deacetylation, Golgi fragmentation, and synaptic deficits rescued by ASOs, provided the first actionable disease mechanism for PACS1 syndrome.","evidence":"HDAC6 activity assay, acetylation blots, confocal Golgi/dendrite imaging, electrophysiology, ASO rescue in mouse model and patient NPCs","pmids":["37848409"],"confidence":"High","gaps":["Whether HDAC6 hyperactivation explains all PACS1 syndrome phenotypes or only neuronal ones","Long-term ASO efficacy and safety in vivo unknown"]},{"year":2025,"claim":"Cryo-EM structure of the Pacs1–Wdr37 complex revealed FBR structural homology to synaptotagmin C2 domains and a phospholipid-binding cleft, redefining the FBR as both a protein- and lipid-recognition module; the R203W residue is surface-exposed but does not disrupt complex formation.","evidence":"Cryo-EM structure, targeted proteolysis, phospholipid binding assays (preprint)","pmids":["41279321"],"confidence":"High","gaps":["Functional role of phospholipid binding in cargo sorting or membrane association not tested in cells","How R203W surface exposure relates to HDAC6 gain-of-interaction requires integration with NMR data"]},{"year":2026,"claim":"NMR structure of the FBR revealed that an intramolecular autoinhibitory contact normally restrains HDAC6 binding, and R203W disrupts this contact, while functional studies showed R203W also impairs dynein-driven retrograde transport through an aberrant PACS1–HDAC6–BICD2 complex, unifying the Golgi fragmentation and cargo mislocalization phenotypes.","evidence":"NMR solution structure, in vitro binding with HDAC6, co-IP of dynein/BICD2 complex, cargo motility assays, HDAC6i/Lis1 rescue","pmids":["41858172","41888583"],"confidence":"High","gaps":["Whether the autoinhibitory mechanism also gates interactions with other partners (AP-1, WDR37) not addressed","Full-length PACS1 structure still unavailable","Therapeutic targeting of the R203W-specific HDAC6 interface not yet achieved"]},{"year":null,"claim":"Key unresolved questions include how PACS1 coordinates its multiple functions (trafficking, nuclear HDAC regulation, apoptosis, ER calcium) through a single FBR scaffold, whether phospholipid binding by the C2-like domain regulates membrane recruitment in vivo, and whether R203W-driven HDAC6 hyperactivation accounts for all clinical features of PACS1 syndrome.","evidence":"","pmids":[],"confidence":"Low","gaps":["Full-length PACS1 structure lacking","No systematic substrate/cargo interactome","ER calcium and apoptotic roles not integrated with trafficking paradigm"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,5,7,8]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[21,25]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,5,21,24]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,2,21]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[7,11]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[18,20]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,2,5,7,8,15,16]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,6,10,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,3,11,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,3,4,12,21]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[10,21,24]}],"complexes":["PACS1-WDR37 complex","PACS1-AP-1 ternary sorting complex","PACS1-CK2-GGA3 scaffold complex"],"partners":["WDR37","HDAC6","AP1M1","FURIN","SORL1","CSNK2A1","GGA3","BICD2"],"other_free_text":[]},"mechanistic_narrative":"PACS1 is a cytosolic sorting adaptor that governs endosome-to-TGN retrieval and regulated secretory trafficking by recognizing CK2-phosphorylated acidic cluster motifs on diverse cargo proteins—including furin, CI-MPR, VAMP4, BACE1, SorLA, nephrocystin, CNGB1b, and viral proteins—and bridging them to clathrin adaptor complexes AP-1 and AP-3 through its furin-binding region (FBR) [PMID:9695949, PMID:11331585, PMID:16977309, PMID:14608369]. Beyond membrane trafficking, PACS1 shuttles between nucleus and cytoplasm via importin-α5/CRM1, stabilizes nuclear HDAC2/HDAC3 to maintain histone deacetylation and genomic integrity, forms a stability complex with WDR37 that controls ER calcium handling and lymphocyte homeostasis, and promotes BAX/BAK oligomerization in intrinsic apoptosis [PMID:34822171, PMID:31988453, PMID:33630350, PMID:28060382]. Structurally, the FBR adopts a synaptotagmin-C2-like fold that binds phospholipids and is auto-inhibited by an intramolecular contact from a central unstructured region; the recurrent R203W de novo mutation disrupts this auto-inhibition, hyperactivating HDAC6 and impairing dynein-dependent retrograde transport, which fragments the Golgi and causes the synaptic and craniofacial defects of PACS1 neurodevelopmental syndrome [PMID:41858172, PMID:37848409, PMID:41888583, PMID:23159249]."},"prefetch_data":{"uniprot":{"accession":"Q6VY07","full_name":"Phosphofurin acidic cluster sorting protein 1","aliases":[],"length_aa":963,"mass_kda":104.9,"function":"Coat protein that is involved in the localization of trans-Golgi network (TGN) membrane proteins that contain acidic cluster sorting motifs. Controls the endosome-to-Golgi trafficking of furin and mannose-6-phosphate receptor by connecting the acidic-cluster-containing cytoplasmic domain of these molecules with the adapter-protein complex-1 (AP-1) of endosomal clathrin-coated membrane pits. Involved in HIV-1 nef-mediated removal of MHC-I from the cell surface to the TGN. Required for normal ER Ca2+ handling in lymphocytes. Together with WDR37, it plays an essential role in lymphocyte development, quiescence and survival. Required for stabilizing peripheral lymphocyte populations (By similarity)","subcellular_location":"Golgi apparatus, trans-Golgi network","url":"https://www.uniprot.org/uniprotkb/Q6VY07/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PACS1","classification":"Not Classified","n_dependent_lines":73,"n_total_lines":1208,"dependency_fraction":0.060430463576158944},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PACS1","total_profiled":1310},"omim":[{"mim_id":"615009","title":"SCHUURS-HOEIJMAKERS SYNDROME; SHMS","url":"https://www.omim.org/entry/615009"},{"mim_id":"610423","title":"PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PACS2","url":"https://www.omim.org/entry/610423"},{"mim_id":"607492","title":"PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; PACS1","url":"https://www.omim.org/entry/607492"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PACS1"},"hgnc":{"alias_symbol":["FLJ10209","KIAA1175"],"prev_symbol":[]},"alphafold":{"accession":"Q6VY07","domains":[{"cath_id":"2.60.40.150","chopping":"98-256","consensus_level":"high","plddt":82.2693,"start":98,"end":256},{"cath_id":"3.40.50","chopping":"545-716","consensus_level":"high","plddt":92.6819,"start":545,"end":716},{"cath_id":"2.60.200.40","chopping":"726-757_817-829_845-882_900-944","consensus_level":"medium","plddt":84.7002,"start":726,"end":944}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6VY07","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6VY07-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6VY07-F1-predicted_aligned_error_v6.png","plddt_mean":64.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PACS1","jax_strain_url":"https://www.jax.org/strain/search?query=PACS1"},"sequence":{"accession":"Q6VY07","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6VY07.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6VY07/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6VY07"}},"corpus_meta":[{"pmid":"9695949","id":"PMC_9695949","title":"PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9695949","citation_count":330,"is_preprint":false},{"pmid":"10707087","id":"PMC_10707087","title":"HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10707087","citation_count":251,"is_preprint":false},{"pmid":"12526811","id":"PMC_12526811","title":"HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12526811","citation_count":247,"is_preprint":false},{"pmid":"11331585","id":"PMC_11331585","title":"PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11331585","citation_count":164,"is_preprint":false},{"pmid":"17855360","id":"PMC_17855360","title":"SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17855360","citation_count":154,"is_preprint":false},{"pmid":"23159249","id":"PMC_23159249","title":"Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23159249","citation_count":104,"is_preprint":false},{"pmid":"17581864","id":"PMC_17581864","title":"HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17581864","citation_count":87,"is_preprint":false},{"pmid":"16977309","id":"PMC_16977309","title":"A PACS-1, GGA3 and CK2 complex regulates CI-MPR trafficking.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16977309","citation_count":78,"is_preprint":false},{"pmid":"16308564","id":"PMC_16308564","title":"Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin and targeting to cilia.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16308564","citation_count":75,"is_preprint":false},{"pmid":"14512558","id":"PMC_14512558","title":"Role of PACS-1 in trafficking of human cytomegalovirus glycoprotein B and virus production.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/14512558","citation_count":59,"is_preprint":false},{"pmid":"22496420","id":"PMC_22496420","title":"An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22496420","citation_count":57,"is_preprint":false},{"pmid":"14608369","id":"PMC_14608369","title":"AP-1 recruitment to VAMP4 is modulated by phosphorylation-dependent binding of PACS-1.","date":"2003","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/14608369","citation_count":55,"is_preprint":false},{"pmid":"28060382","id":"PMC_28060382","title":"Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28060382","citation_count":54,"is_preprint":false},{"pmid":"26842493","id":"PMC_26842493","title":"Clinical delineation of the PACS1-related syndrome--Report on 19 patients.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26842493","citation_count":49,"is_preprint":false},{"pmid":"24001769","id":"PMC_24001769","title":"SORLA-dependent and -independent functions for PACS1 in control of amyloidogenic processes.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24001769","citation_count":30,"is_preprint":false},{"pmid":"19710307","id":"PMC_19710307","title":"PACS-1 mediates phosphorylation-dependent ciliary trafficking of the cyclic-nucleotide-gated channel in olfactory sensory neurons.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19710307","citation_count":30,"is_preprint":false},{"pmid":"33028635","id":"PMC_33028635","title":"Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33028635","citation_count":28,"is_preprint":false},{"pmid":"33630350","id":"PMC_33630350","title":"Calcium flux control by Pacs1-Wdr37 promotes lymphocyte quiescence and lymphoproliferative diseases.","date":"2021","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33630350","citation_count":26,"is_preprint":false},{"pmid":"28946017","id":"PMC_28946017","title":"Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28946017","citation_count":24,"is_preprint":false},{"pmid":"31988453","id":"PMC_31988453","title":"The multifunctional protein PACS-1 is required for HDAC2- and HDAC3-dependent chromatin maturation and genomic stability.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31988453","citation_count":23,"is_preprint":false},{"pmid":"34068396","id":"PMC_34068396","title":"Schuurs-Hoeijmakers Syndrome (PACS1 Neurodevelopmental Disorder): Seven Novel Patients and a Review.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34068396","citation_count":20,"is_preprint":false},{"pmid":"28975623","id":"PMC_28975623","title":"A novel missense mutation affecting the same amino acid as the recurrent PACS1 mutation in Schuurs-Hoeijmakers syndrome.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28975623","citation_count":20,"is_preprint":false},{"pmid":"34594577","id":"PMC_34594577","title":"miR-485-5p alleviates Alzheimer's disease progression by targeting PACS1.","date":"2021","source":"Translational neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34594577","citation_count":19,"is_preprint":false},{"pmid":"37848409","id":"PMC_37848409","title":"Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37848409","citation_count":16,"is_preprint":false},{"pmid":"31759187","id":"PMC_31759187","title":"PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA.","date":"2019","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/31759187","citation_count":15,"is_preprint":false},{"pmid":"34517877","id":"PMC_34517877","title":"PACS1-Neurodevelopmental disorder: clinical features and trial readiness.","date":"2021","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34517877","citation_count":14,"is_preprint":false},{"pmid":"38280846","id":"PMC_38280846","title":"iPSC-derived models of PACS1 syndrome reveal transcriptional and functional deficits in neuron activity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38280846","citation_count":14,"is_preprint":false},{"pmid":"36077045","id":"PMC_36077045","title":"Molecular Basis of the Schuurs-Hoeijmakers Syndrome: What We Know about the Gene and the PACS-1 Protein and Novel Therapeutic Approaches.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36077045","citation_count":14,"is_preprint":false},{"pmid":"32903913","id":"PMC_32903913","title":"Renpenning Syndrome in a Turkish Patient: de novo Variant c.607C>T in PACS1 and Hypogammaglobulinemia Phenotype.","date":"2020","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/32903913","citation_count":13,"is_preprint":false},{"pmid":"29550517","id":"PMC_29550517","title":"Ocular manifestations of PACS1 mutation.","date":"2018","source":"Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus","url":"https://pubmed.ncbi.nlm.nih.gov/29550517","citation_count":12,"is_preprint":false},{"pmid":"33369122","id":"PMC_33369122","title":"Coloboma may be a shared feature in a spectrum of disorders caused by mutations in the WDR37-PACS1-PACS2 axis.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33369122","citation_count":11,"is_preprint":false},{"pmid":"34822171","id":"PMC_34822171","title":"PACS-1 contains distinct motifs for nuclear-cytoplasmic transport and interacts with the RNA-binding protein PTBP1 in the nucleus and cytosol.","date":"2021","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/34822171","citation_count":8,"is_preprint":false},{"pmid":"30458990","id":"PMC_30458990","title":"PACS-1 and adaptor protein-1 mediate ACTH trafficking to the regulated secretory pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30458990","citation_count":5,"is_preprint":false},{"pmid":"37141437","id":"PMC_37141437","title":"Do PACS1 variants impeding adaptor protein binding predispose to syndromic intellectual disability?","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/37141437","citation_count":4,"is_preprint":false},{"pmid":"39031646","id":"PMC_39031646","title":"PACS-1 variant protein is aberrantly localized in Caenorhabditis elegans model of PACS1/PACS2 syndromes.","date":"2024","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39031646","citation_count":4,"is_preprint":false},{"pmid":"40004556","id":"PMC_40004556","title":"Expanding the Clinical Spectrum Associated with the Recurrent Arg203Trp Variant in PACS1: An Italian Cohort Study.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40004556","citation_count":2,"is_preprint":false},{"pmid":"36415352","id":"PMC_36415352","title":"A Novel PACS1 Variant Associated With Schuurs-Hoeijmakers Syndrome Phenotype in an Indigenous Descendant in Brazil: A Case Report.","date":"2022","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/36415352","citation_count":2,"is_preprint":false},{"pmid":"39157130","id":"PMC_39157130","title":"PACS-1 Interacts with TRPC3 and ESyt1 to Mediate Protein Trafficking while Promoting SOCE and Cooperatively Regulating Hormone Secretion.","date":"2024","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/39157130","citation_count":2,"is_preprint":false},{"pmid":"37064331","id":"PMC_37064331","title":"First Report of Mexican Patients with PACS1-Related Neurodevelopmental Disorder and Review of the PACS1-, PACS2-, and WDR37-Related Ophthalmological Manifestations.","date":"2022","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/37064331","citation_count":2,"is_preprint":false},{"pmid":"36747781","id":"PMC_36747781","title":"RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/36747781","citation_count":1,"is_preprint":false},{"pmid":"39911171","id":"PMC_39911171","title":"PACS2, PACS1, and VACTERL: A Clinical Overlap.","date":"2024","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/39911171","citation_count":1,"is_preprint":false},{"pmid":"37218682","id":"PMC_37218682","title":"A case report of retinal dystrophy in patients with PACS1 syndrome.","date":"2023","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37218682","citation_count":1,"is_preprint":false},{"pmid":"33994196","id":"PMC_33994196","title":"WITHDRAWN: Schuurs-Hoeijmakers syndrome: Severe expression of the recurrent PACS1 c.607C>T mutation.","date":"2021","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/33994196","citation_count":1,"is_preprint":false},{"pmid":"40869285","id":"PMC_40869285","title":"AI-Based Facial Phenotyping Supports a Shared Molecular Axis in PACS1-, PACS2-, and WDR37-Related Syndromes.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40869285","citation_count":1,"is_preprint":false},{"pmid":"41888583","id":"PMC_41888583","title":"PACS1 syndrome mutation disrupts dynein-mediated cargo transport via HDAC6 and BICD2.","date":"2026","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41888583","citation_count":0,"is_preprint":false},{"pmid":"41279321","id":"PMC_41279321","title":"The Structural Basis for Pacs1-Wdr37 Complex Assembly and Stability.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41279321","citation_count":0,"is_preprint":false},{"pmid":"37747683","id":"PMC_37747683","title":"Genetic characterization of Schuurs-Hoeijmakers syndrome in a moroccan individual with heterozygote PACS1 mutation.","date":"2023","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/37747683","citation_count":0,"is_preprint":false},{"pmid":"41882293","id":"PMC_41882293","title":"DNA methylation signature and clinical delineation of PACS1-related disorder in 24 unreported individuals.","date":"2026","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/41882293","citation_count":0,"is_preprint":false},{"pmid":"38712144","id":"PMC_38712144","title":"PACS-1 variant protein is aberrantly localized in C. elegans model of PACS1/PACS2 syndromes.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38712144","citation_count":0,"is_preprint":false},{"pmid":"41497635","id":"PMC_41497635","title":"PACS1 syndrome variant alters proteomic landscape of developing cortical organoids.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41497635","citation_count":0,"is_preprint":false},{"pmid":"41858172","id":"PMC_41858172","title":"The R203W substitution drives PACS-1 syndrome by disrupting intramolecular regulation.","date":"2026","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/41858172","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.01.662510","title":"The effect of environmental enrichment on immune cell DNA methylation profiles depends on the parity of sows","date":"2025-07-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.01.662510","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.05.24310862","title":"Genotypic and phenotypic analysis of 173 patients with extremely rare pathogenic mutations who applied for experimental antisense oligonucleotide treatment","date":"2024-08-06","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.05.24310862","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.27.24319460","title":"Deleterious coding variation associated with autism is consistent across populations, as exemplified by admixed Latin American populations","date":"2025-01-06","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.27.24319460","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25533,"output_tokens":6548,"usd":0.08741},"stage2":{"model":"claude-opus-4-6","input_tokens":10157,"output_tokens":3846,"usd":0.220403},"total_usd":0.307813,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"PACS-1 directs TGN localization of furin by binding to the protease's phosphorylated cytosolic acidic cluster domain, acting as a coat protein that connects furin to clathrin-sorting machinery; cell-free assays showed TGN localization is directed by a PACS-1-mediated retrieval step from endosomes.\",\n      \"method\": \"In vitro binding assays, cell-free TGN localization assays, antisense studies, co-immunoprecipitation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution in cell-free assay, multiple orthogonal methods, foundational paper with 330 citations\",\n      \"pmids\": [\"9695949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HIV-1 Nef binds PACS-1 via its acidic cluster (EEEE motif) to redirect internalized MHC-I from the cell surface to the TGN; Nef acts as a connector between MHC-I cytoplasmic tail and the PACS-1-dependent sorting pathway.\",\n      \"method\": \"Co-immunoprecipitation, chimeric protein localization, dominant-negative PACS-1 expression, confocal microscopy\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal functional assays, replicated mechanistic finding, 251 citations\",\n      \"pmids\": [\"10707087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PACS-1 associates with adaptor complexes AP-1 and AP-3 (but not AP-2), forming a ternary complex with furin and AP-1; a short sequence in PACS-1 is essential for AP-1 binding, and dominant-negative PACS-1 (which binds cargo but not adaptors) mislocalizes furin, mannose-6-phosphate receptor, and blocks Nef-mediated MHC-I downregulation.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative mutant expression, subcellular fractionation, immunofluorescence\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, dominant-negative rescue experiments with defined phenotype, 164 citations\",\n      \"pmids\": [\"11331585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Nef and PACS-1 combine to usurp the ARF6 endocytic pathway in a PI3K-dependent manner to downregulate cell-surface MHC-I to the TGN; three hierarchical Nef motifs (acidic cluster EEEE65, SH3-binding PXXP, and M20) control PACS-1-dependent TGN sorting, ARF6 activation, and MHC-I sequestration, respectively.\",\n      \"method\": \"Dominant-negative constructs, RNA interference, epistasis analysis, immunofluorescence, co-immunoprecipitation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with multiple Nef motif mutants, mechanistic dissection with defined phenotypic readouts, 247 citations\",\n      \"pmids\": [\"12526811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PACS-1 interacts with the cytoplasmic acidic cluster domain of HCMV glycoprotein B (gB) and is required for normal TGN localization of gB; inhibition of PACS-1 decreases HCMV titer while overexpression increases titer.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PACS-1 expression, virus titer assays, immunofluorescence\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional rescue with overexpression/inhibition plus binding assays, multiple orthogonal methods\",\n      \"pmids\": [\"14512558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PACS-1 mediates phosphorylation-dependent recruitment to VAMP4 by binding the phosphorylated acidic cluster (Ser30) of VAMP4, thereby enhancing AP-1 association with VAMP4 cargo; dominant-negative PACS-1 causes mislocalization of VAMP4 in the regulated secretory pathway.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PACS-1 expression, immunofluorescence, casein kinase 2 phosphorylation assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with defined cargo phosphorylation and phenotypic readout\",\n      \"pmids\": [\"14608369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PACS-1 interacts with nephrocystin in a CK2-phosphorylation-dependent manner; CK2 phosphorylation of three critical serines in nephrocystin's acidic cluster mediates PACS-1 binding and is essential for nephrocystin localization to the base of cilia; CK2 inhibition disrupts this interaction and abrogates correct nephrocystin targeting.\",\n      \"method\": \"Co-immunoprecipitation, kinase inhibition assays, immunofluorescence, dominant-negative studies\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — phosphorylation mechanism defined with multiple methods and functional consequence (ciliary targeting)\",\n      \"pmids\": [\"16308564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PACS-1 forms a multimeric complex with GGA3 and CK2 that controls CI-MPR sorting; PACS-1-bound CK2 phosphorylates GGA3 (releasing it from CI-MPR/endosomes) and phosphorylates PACS-1 Ser278 (promoting PACS-1 binding to CI-MPR for retrieval to TGN), constituting a CK2-controlled phosphorylation cascade.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assays, dominant-negative constructs, phospho-specific antibodies, immunofluorescence\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay plus multiple orthogonal in vivo methods defining a phosphorylation cascade\",\n      \"pmids\": [\"16977309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PACS-1 is required for SorLA localization to TGN compartments; SorLA interaction with PACS-1 (and GGA) controls intracellular routing of SorLA/APP complexes, and aberrant SorLA targeting caused by loss of PACS-1 function results in increased amyloidogenic APP processing.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PACS-1, siRNA knockdown, immunofluorescence, ELISA for Aβ\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assays plus loss-of-function with defined biochemical readout (Aβ production)\",\n      \"pmids\": [\"17855360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Knockdown of PACS-1 by siRNA does not inhibit Nef-mediated downregulation of HLA-A2 in HeLa cells, and does not affect localization of other acidic-cluster-motif proteins; instead, AP-1 and clathrin are required, and Nef reroutes MHC-I to endosomes rather than TGN.\",\n      \"method\": \"siRNA knockdown, immunoelectron microscopy, flow cytometry, immunofluorescence\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean siRNA KD with defined phenotypic readout, but contradicts prior model; single lab study\",\n      \"pmids\": [\"17581864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PACS-1 is expressed in olfactory sensory neurons and interacts with the CNG channel subunit CNGB1b; CK2 phosphorylates two acidic cluster sites on CNGB1b to enable PACS-1 binding; CK2 inhibition or dominant-negative PACS-1 expression causes loss of CNG channel from cilia and olfactory dysfunction.\",\n      \"method\": \"Co-immunoprecipitation, adenoviral dominant-negative expression, CK2 inhibition, electrophysiology, immunofluorescence\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with defined functional consequence (olfactory dysfunction), phosphorylation mechanism validated\",\n      \"pmids\": [\"19710307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HIV-1 Nef interacts with PACS-1 and PACS-2 through a bipartite site on Nef (EEEE65 acidic cluster and W113 in core domain) engaging a previously unidentified cargo subsite on PACS proteins; this interaction occurs on Rab5/Rab7-positive endosomes and is required for Nef-mediated MHC-I downregulation in PBMCs.\",\n      \"method\": \"Bimolecular fluorescence complementation, site-directed mutagenesis, co-immunoprecipitation, flow cytometry, immunofluorescence\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of interacting sites with multiple orthogonal in vivo/in cellulo methods and functional readout\",\n      \"pmids\": [\"22496420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Recurrent de novo PACS1 mutation (p.Arg203Trp) causes PACS1 protein to form cytoplasmic aggregates with increased protein stability, shows impaired binding to an isoform-specific TRPV4 variant, and expression of mutant PACS1 mRNA in zebrafish induces craniofacial defects by disrupting SOX10-positive cranial neural crest cell specification and migration.\",\n      \"method\": \"In vitro aggregation assay, co-immunoprecipitation (binding to TRPV4), zebrafish mRNA injection, in situ hybridization (SOX10 marker)\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including in vivo zebrafish model with defined cellular phenotype\",\n      \"pmids\": [\"23159249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PACS1 interaction with SORLA is required for SORLA/APP complex sorting to the TGN in neurons; disruption of SORLA-PACS1 interaction (by PACS1 knockdown or PACS1-binding-defective SORLA knock-in mice) increases APP processing in the brain; PACS1 loss also impairs CI-MPR and cathepsin B expression, reducing Aβ degradation.\",\n      \"method\": \"siRNA knockdown in neuronal lines, transgenic knock-in mice with PACS1-binding-defective SORLA, ELISA for Aβ, immunofluorescence\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse model plus neuronal cell line KD with defined biochemical readout\",\n      \"pmids\": [\"24001769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PACS1 regulates intrinsic (mitochondrial) apoptosis: PACS1 knockdown renders cells refractory to mitochondrial pathway death stimuli (granzyme B, staurosporine, UV, etoposide) but not TRAIL; protected cells fail to release cytochrome c due to perturbed BAX and BAK oligomerization; PCAF and ADA3 transcriptionally regulate PACS1 expression.\",\n      \"method\": \"siRNA knockdown, cytochrome c release assay, BAX/BAK oligomerization assay, cell death assays, ChIP\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with multiple death stimuli tested and molecular readout (BAX/BAK oligomerization, cytochrome c), multiple orthogonal methods\",\n      \"pmids\": [\"28060382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Par3 promotes BACE1 retrograde trafficking from endosomes to TGN through aPKC-mediated phosphorylation of BACE1 Ser498, which promotes BACE1 interaction with PACS-1 and facilitates endosome-to-TGN retrieval; decreased Ser498 phosphorylation is found in AD brains.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis, dominant-negative aPKC, immunofluorescence, human AD brain phospho-western blot\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — phosphorylation-dependent binding mechanistically defined with mutagenesis and loss-of-function, validated in human tissue\",\n      \"pmids\": [\"28946017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PACS-1 and AP-1 are required for targeting POMC/ACTH to dense core secretory granules (DCSGs); knockdown of PACS-1 or AP-1 causes POMC to be secreted constitutively rather than sorted to DCSGs.\",\n      \"method\": \"siRNA knockdown, ELISA for secreted ACTH, immunofluorescence\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — KD with phenotypic readout but single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"30458990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PACS1 shuttles between nucleus and cytoplasm, associates with HIV-1 Rev protein and its cofactor CRM1, and promotes nuclear export of unspliced viral RNA; overexpression increases nuclear export and p24 expression, while siRNA depletion reduces viral RNA export via the Rev-CRM1 pathway.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, nuclear fractionation, RT-PCR for viral RNA\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, co-IP plus KD/OE with viral RNA export readout, but limited mechanistic follow-up\",\n      \"pmids\": [\"31759187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PACS-1 accumulates in the nucleus during cell cycle progression and interacts with HDAC2 and HDAC3; PACS-1 knockdown causes proteasome-mediated degradation of HDAC2/HDAC3, elevated H3K9 and H4K16 acetylation, and increased replication stress-induced DNA damage and genomic instability.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, immunofluorescence, histone acetylation western blots, comet assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP plus KD with defined chromatin/genomic readout; single lab but multiple methods\",\n      \"pmids\": [\"31988453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Pacs1 forms a complex with Wdr37 that is required for normal ER calcium handling in lymphocytes; deletion of Pacs1 causes peripheral lymphopenia, blunted Ca2+ release from ER after antigen receptor stimulation, diminished inositol triphosphate receptor expression, and increased ER/oxidative stress; disruption of Pacs1-Wdr37 also suppresses lymphoproliferative disease.\",\n      \"method\": \"Forward genetic screen in mice, Pacs1 knockout, calcium imaging, IP3R expression western blot, in vivo lymphoproliferation models\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse KO with multiple mechanistic readouts, forward genetic screen origin adds robustness\",\n      \"pmids\": [\"33630350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PACS-1 nuclear trafficking is mediated by interaction with importin alpha 5 (nuclear entry) and exportin 1/CRM1 (nuclear exit); a nuclear localization signal (NLS, residues 311-318) and nuclear export signal (NES3, residues 366-375) were identified; PACS-1 also forms a complex with RNA-binding protein PTBP1 in both nucleus and cytoplasm.\",\n      \"method\": \"Site-directed mutagenesis of NLS/NES, co-immunoprecipitation with importin alpha 5 and exportin 1, immunofluorescence of NLS/NES mutants\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of transport signals with localization readout; single lab\",\n      \"pmids\": [\"34822171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PACS1 is an HDAC6 effector; the R203W substitution increases the PACS1/HDAC6 interaction, aberrantly potentiating deacetylase activity; this reduces acetylation of α-tubulin and cortactin, causing Golgi ribbon fragmentation and overpopulation of dendrites, increased dendritic arborization, varicosities, reduced spine density, and fewer functional synapses in hippocampal neurons and patient-derived NPCs; treatment with PACS1- or HDAC6-targeting antisense oligonucleotides restores neuronal structure and synaptic transmission.\",\n      \"method\": \"Co-immunoprecipitation, HDAC6 activity assay, acetylation western blots, confocal microscopy of Golgi/dendrites, electrophysiology, ASO treatment in PACS1 syndrome mice\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro enzymatic assay + mutagenesis + in vivo rescue with multiple orthogonal methods in patient cells and mouse model\",\n      \"pmids\": [\"37848409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PACS-1 interacts with TRPC3 calcium transporter and ESyt1 ER-plasma membrane tethering protein; PACS-1 promotes TRPC3-ESyt1 interactions and regulates their plasma membrane localization; PACS-1 is required for proper store-operated calcium entry (SOCE) response and for ESyt1-mediated regulation of ACTH secretion in corticotropic cells.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, calcium imaging (SOCE assay), immunofluorescence, ACTH secretion ELISA\",\n      \"journal\": \"ACS omega\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — binding plus functional calcium assay and secretion readout; single lab\",\n      \"pmids\": [\"39157130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure of the Pacs1-Wdr37 complex shows Pacs1 binds Wdr37 through its furin-binding region (FBR); this interaction stabilizes Wdr37 and is critical for expression of both proteins; the FBR has structural homology to synaptotagmin C2 domains and can bind negatively charged phospholipids through a unique positively charged cleft; the R203W pathogenic mutation lies on a solvent-exposed surface of the FBR and does not disrupt complex formation but remains dependent on Wdr37 for stability.\",\n      \"method\": \"Cryo-electron microscopy structure determination, targeted proteolysis, phospholipid binding assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure with functional validation of binding interface and phospholipid interaction\",\n      \"pmids\": [\"41279321\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Cytoplasmic dynein-1 heavy chain (DHC1) is a PACS1 interactor essential for maintaining furin localization at the TGN; PACS1R203W induces a dynein loss-of-function phenotype by recruiting BICD2 adaptor and forming a PACS1R203W-HDAC6-BICD2 complex that disperses the Golgi and impairs dynein-driven cargo motility (reduced initiation frequency and velocity); HDAC6 inhibition or Lis1 overexpression rescues dynein function.\",\n      \"method\": \"Co-immunoprecipitation, cargo motility assays, HDAC6 inhibition rescue, dominant-negative Lis1, immunofluorescence of Golgi/furin\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods defining complex, functional motility readout, and pharmacological rescue\",\n      \"pmids\": [\"41888583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NMR solution structure of PACS-1 furin-binding region (FBR, residues 101-273) shows that the PACS-1/HDAC6 interaction is regulated by an intramolecular mechanism in which the central unstructured region of PACS-1 folds back across the FBR to engage a positively charged loop; the R203W substitution disrupts this intramolecular regulatory contact in vitro, promoting aberrant protein-protein interactions.\",\n      \"method\": \"NMR solution structure determination, in vitro binding assays with HDAC6, mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional validation of intramolecular regulatory mechanism and mutagenesis\",\n      \"pmids\": [\"41858172\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PACS-1 is a multifunctional cytosolic sorting protein whose furin-binding region (FBR) recognizes phosphorylated acidic cluster motifs on cargo proteins (furin, CI-MPR, VAMP4, BACE1, SorLA, nephrocystin, viral glycoproteins) and connects them to clathrin adaptor complexes (AP-1, AP-3) for CK2-regulated retrieval from endosomes to the TGN; it also acts as an HDAC6 effector controlling Golgi integrity and neuronal morphology, forms a stability complex with WDR37 through its FBR that can bind phospholipids, mediates nucleocytoplasmic shuttling via importin alpha 5 and CRM1, regulates ER calcium handling in lymphocytes through a Pacs1-Wdr37 complex, promotes BAX/BAK oligomerization in the intrinsic apoptosis pathway, and interacts with dynein/BICD2 to drive retrograde cargo transport; the recurrent R203W mutation disrupts an intramolecular regulatory mechanism within the FBR that normally restrains HDAC6 binding, leading to aberrant HDAC6 hyperactivation, tubulin/cortactin deacetylation, dynein dysfunction, Golgi fragmentation, and neuronal synaptic deficits characteristic of PACS1 neurodevelopmental syndrome.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PACS1 is a cytosolic sorting adaptor that governs endosome-to-TGN retrieval and regulated secretory trafficking by recognizing CK2-phosphorylated acidic cluster motifs on diverse cargo proteins—including furin, CI-MPR, VAMP4, BACE1, SorLA, nephrocystin, CNGB1b, and viral proteins—and bridging them to clathrin adaptor complexes AP-1 and AP-3 through its furin-binding region (FBR) [PMID:9695949, PMID:11331585, PMID:16977309, PMID:14608369]. Beyond membrane trafficking, PACS1 shuttles between nucleus and cytoplasm via importin-α5/CRM1, stabilizes nuclear HDAC2/HDAC3 to maintain histone deacetylation and genomic integrity, forms a stability complex with WDR37 that controls ER calcium handling and lymphocyte homeostasis, and promotes BAX/BAK oligomerization in intrinsic apoptosis [PMID:34822171, PMID:31988453, PMID:33630350, PMID:28060382]. Structurally, the FBR adopts a synaptotagmin-C2-like fold that binds phospholipids and is auto-inhibited by an intramolecular contact from a central unstructured region; the recurrent R203W de novo mutation disrupts this auto-inhibition, hyperactivating HDAC6 and impairing dynein-dependent retrograde transport, which fragments the Golgi and causes the synaptic and craniofacial defects of PACS1 neurodevelopmental syndrome [PMID:41858172, PMID:37848409, PMID:41888583, PMID:23159249].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The discovery that furin's TGN localization depends on a cytosolic adaptor recognizing its phosphorylated acidic cluster established PACS-1 as a new class of CK2-regulated sorting protein linking cargo to clathrin machinery.\",\n      \"evidence\": \"Cell-free TGN retrieval assay, in vitro binding, antisense knockdown in A7 melanoma cells\",\n      \"pmids\": [\"9695949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural information on the cargo-recognition domain\", \"Identity of clathrin adaptor partner not yet defined\", \"Generality to non-furin cargo unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of AP-1 and AP-3 (but not AP-2) as PACS-1 effector adaptors, and demonstration that dominant-negative PACS-1 mislocalizes furin, CI-MPR, and blocks Nef-mediated MHC-I downregulation, established the ternary cargo–PACS-1–adaptor sorting paradigm.\",\n      \"evidence\": \"Co-immunoprecipitation, dominant-negative PACS-1 expression, subcellular fractionation in multiple cell lines\",\n      \"pmids\": [\"11331585\", \"10707087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CK2 phosphorylation of PACS-1 itself regulates adaptor binding was unknown\", \"Whether PACS-1 requirement for Nef-MHC-I pathway is cell-type-dependent\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extension of the PACS-1 cargo repertoire to VAMP4 and HCMV glycoprotein B demonstrated that CK2-phosphorylated acidic clusters are a general sorting signal decoded by PACS-1 in both endogenous secretory and viral trafficking pathways.\",\n      \"evidence\": \"Co-IP, CK2 kinase assays, dominant-negative PACS-1, virus titer assays\",\n      \"pmids\": [\"14608369\", \"14512558\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for acidic-cluster selectivity unresolved\", \"Role in neuronal cargo not yet tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that PACS-1 scaffolds a CK2–GGA3 phosphorylation cascade controlling CI-MPR endosome-to-TGN retrieval revealed PACS-1 as both a kinase scaffold and a regulated cargo receptor whose own Ser278 phosphorylation gates cargo binding.\",\n      \"evidence\": \"In vitro kinase assays, phospho-specific antibodies, dominant-negative constructs, immunofluorescence\",\n      \"pmids\": [\"16977309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the CK2–PACS-1 complex regulates additional substrates beyond GGA3 is unexplored\", \"In vivo validation of the cascade lacking\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linking PACS-1 to SorLA/APP trafficking in neurons showed that loss of PACS-1-mediated TGN retrieval increases amyloidogenic APP processing, connecting the sorting adaptor to Alzheimer's disease-relevant biology.\",\n      \"evidence\": \"Co-IP, siRNA, dominant-negative PACS-1, Aβ ELISA in neuronal cells; later confirmed in PACS1-binding-defective SorLA knock-in mice\",\n      \"pmids\": [\"17855360\", \"24001769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PACS1 loss affects Aβ clearance pathways independently of SorLA\", \"Human genetic association of PACS1 with AD risk not established\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstration that PACS-1 directs CNG channel subunit CNGB1b to olfactory cilia via CK2-dependent acidic cluster recognition extended the paradigm from Golgi/TGN sorting to ciliary targeting, with functional consequences for sensory neuron physiology.\",\n      \"evidence\": \"Co-IP, CK2 inhibition, dominant-negative adenoviral PACS-1, electrophysiology in olfactory neurons\",\n      \"pmids\": [\"19710307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PACS-1 accompanies cargo to the cilium or hands off to IFT machinery unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of the recurrent R203W de novo mutation as the cause of PACS1 neurodevelopmental syndrome, with demonstration that mutant protein forms cytoplasmic aggregates and disrupts cranial neural crest specification in zebrafish, established PACS1 as a disease gene and implicated FBR integrity in brain development.\",\n      \"evidence\": \"Human exome sequencing, in vitro aggregation assay, zebrafish mRNA injection, SOX10 in situ hybridization\",\n      \"pmids\": [\"23159249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which R203W causes aggregation unresolved\", \"Whether gain-of-function or dominant-negative effect uncertain at this stage\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovery that PACS1 knockdown blocks BAX/BAK oligomerization and cytochrome c release revealed an unexpected role in the intrinsic apoptotic pathway, broadening PACS1 function beyond membrane trafficking.\",\n      \"evidence\": \"siRNA knockdown, cytochrome c release assay, BAX/BAK oligomerization, multiple death stimuli panel\",\n      \"pmids\": [\"28060382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical mechanism linking PACS1 to BAX/BAK oligomerization not identified\", \"Whether this reflects a trafficking-dependent or trafficking-independent function unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Finding that nuclear PACS-1 stabilizes HDAC2/HDAC3 to maintain histone deacetylation and protect against replication-stress-induced DNA damage revealed a chromatin-regulatory function separate from its TGN sorting role.\",\n      \"evidence\": \"Co-IP with HDAC2/HDAC3, siRNA, histone acetylation western blots, comet assay\",\n      \"pmids\": [\"31988453\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PACS-1 directly shields HDACs from proteasomal targeting or acts indirectly is unclear\", \"Independent replication needed\", \"Relationship to cell-cycle-dependent nuclear accumulation not fully defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Forward genetic identification of Pacs1–Wdr37 as a complex essential for ER calcium handling, IP3R expression, and lymphocyte survival established PACS1 in ER-related signaling and immune homeostasis.\",\n      \"evidence\": \"Mouse Pacs1 knockout, calcium imaging, IP3R western blot, in vivo lymphoproliferation models\",\n      \"pmids\": [\"33630350\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the Pacs1–Wdr37 complex controls IP3R expression (transcriptional vs. post-translational) unknown\", \"Whether the ER calcium defect contributes to PACS1 syndrome neuronal phenotypes untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstration that PACS1 is an HDAC6 effector and that R203W hyperactivates HDAC6 deacetylase activity, causing tubulin/cortactin deacetylation, Golgi fragmentation, and synaptic deficits rescued by ASOs, provided the first actionable disease mechanism for PACS1 syndrome.\",\n      \"evidence\": \"HDAC6 activity assay, acetylation blots, confocal Golgi/dendrite imaging, electrophysiology, ASO rescue in mouse model and patient NPCs\",\n      \"pmids\": [\"37848409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC6 hyperactivation explains all PACS1 syndrome phenotypes or only neuronal ones\", \"Long-term ASO efficacy and safety in vivo unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM structure of the Pacs1–Wdr37 complex revealed FBR structural homology to synaptotagmin C2 domains and a phospholipid-binding cleft, redefining the FBR as both a protein- and lipid-recognition module; the R203W residue is surface-exposed but does not disrupt complex formation.\",\n      \"evidence\": \"Cryo-EM structure, targeted proteolysis, phospholipid binding assays (preprint)\",\n      \"pmids\": [\"41279321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of phospholipid binding in cargo sorting or membrane association not tested in cells\", \"How R203W surface exposure relates to HDAC6 gain-of-interaction requires integration with NMR data\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"NMR structure of the FBR revealed that an intramolecular autoinhibitory contact normally restrains HDAC6 binding, and R203W disrupts this contact, while functional studies showed R203W also impairs dynein-driven retrograde transport through an aberrant PACS1–HDAC6–BICD2 complex, unifying the Golgi fragmentation and cargo mislocalization phenotypes.\",\n      \"evidence\": \"NMR solution structure, in vitro binding with HDAC6, co-IP of dynein/BICD2 complex, cargo motility assays, HDAC6i/Lis1 rescue\",\n      \"pmids\": [\"41858172\", \"41888583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the autoinhibitory mechanism also gates interactions with other partners (AP-1, WDR37) not addressed\", \"Full-length PACS1 structure still unavailable\", \"Therapeutic targeting of the R203W-specific HDAC6 interface not yet achieved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include how PACS1 coordinates its multiple functions (trafficking, nuclear HDAC regulation, apoptosis, ER calcium) through a single FBR scaffold, whether phospholipid binding by the C2-like domain regulates membrane recruitment in vivo, and whether R203W-driven HDAC6 hyperactivation accounts for all clinical features of PACS1 syndrome.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Full-length PACS1 structure lacking\", \"No systematic substrate/cargo interactome\", \"ER calcium and apoptotic roles not integrated with trafficking paradigm\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 5, 7, 8]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [21, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 5, 21, 24]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 2, 21]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [7, 11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [18, 20]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2, 5, 7, 8, 15, 16]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 6, 10, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 3, 11, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 3, 4, 12, 21]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [10, 21, 24]}\n    ],\n    \"complexes\": [\n      \"PACS1-WDR37 complex\",\n      \"PACS1-AP-1 ternary sorting complex\",\n      \"PACS1-CK2-GGA3 scaffold complex\"\n    ],\n    \"partners\": [\n      \"WDR37\",\n      \"HDAC6\",\n      \"AP1M1\",\n      \"FURIN\",\n      \"SORL1\",\n      \"CSNK2A1\",\n      \"GGA3\",\n      \"BICD2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}